Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
561. |
ECCT/25/05/10 | Field Evaluation for STI POC Evaluation of a Point-of-Care (PoC) diagnostic device to improve sexually Transmitted Infections Management and outcomes in Kenya: SERU PROTOCOL NO. NON KEMRI 5074 Enable GingerCannot connect to Ginger Check your internet connection or reload the browserDisable Ginger?How to use GingerRephraseRephrase with Ginger (Ctrl+Alt+E)Edit in GingerGinger is checking your text for mistakes...Disable Ginger in this text fieldDisable Ginger on this website× Enable GingerCannot connect to Ginger Check your internet connection or reload the browserDisable Ginger?How to use GingerRephraseRephrase with Ginger (Ctrl+Alt+E)Edit in GingerGinger is checking your text for mistakes...Disable Ginger in this text fieldDisable Ginger on this website× |
Principal Investigator(s) 1. Patricia Ongwen 2. Dismas Ouma 3. Rose Wafula Site(s) in Kenya International Centre for Reproductive Health -Kenya |
29-04-2026 |
View |
562. |
ECCT/25/08/08 | PROPS Trial Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial (Probiotics in preterm and small for gestational age infants, PROPS trial) |
Principal Investigator(s) 1. Maureen Muchela Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 2. Homabay County Referral Hospital (Homa Bay county) 3. Kisii Teaching and Referral Hospital (Kisii county) 4. Migori County Referral Hospital (Migori county) |
29-04-2026 |
View |
563. |
ECCT/26/02/04 | RSV IMPACT TRIAL A Phase-IIIb individually randomized, placebo-controlled trial on safety of RSVA/B-preF vaccine in pregnant women and efficacy against severe RSV-associated lower respiratory tract infection (LRTI) in infants. |
Principal Investigator(s) 1. Joyce Uchi Nyiro 2. Makobu Kimani Site(s) in Kenya 1. Kilifi, KEMRI-Centre for Geographic Medicine Research Coast (CGMRC) (Kilifi county) |
28-05-2026 |
View |
564. |
ECCT/26/03/02 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. St Marys Mission Hospital-Langata (Nairobi City county) 2. Mbagathi County Referral Hospital (Nairobi City county) |
04-06-2026 |
View |
565. |
ECCT/26/02/01 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. Mbagathi County Referral Hospital (Nairobi City county) |
19-06-2026 |
View |
566. |
ECCT/26/02/08 | SOAR Study Optimizing Smoking Cessation and Unhealthy Alcohol Use Treatment Among People Living with Human Immunodeficiency Virus (PLWH) In Nairobi, Kenya Abbreviated as SOAR Study Smoking cessation Optimization and unhealthy Alcohol use Research, SOAR, Study. |
Principal Investigator(s) 1. DR. EMILY KOECH Site(s) in Kenya Riruta Hospital |
19-06-2026 |
View |
567. |
ECCT/25/11/01 | COMBO-CONSTELLATION A Phase 3, randomized, double-blind, placebo-controlled trial to evaluate the effect of Bifidobacterium longum subsp. infantis DSM33361(Bifin02) administered together with Lacticaseibacillus rhamnosus GG DSM33156 (LGG®) versus placebo on weight gain in underweight infants |
Principal Investigator(s) 1. Dr. Wilson Muraya Site(s) in Kenya 1. KENYA MEDICAL RESEARCH INSTITUTE- MTWAPA (Kilifi county) 2. Moi University Clinical Research Centre-MUCRU (Uasin Gishu county) 3. Kenya Medical Research Institute (KEMRI) CRDR (Nairobi City county) |
21-06-2026 |
View |
568. |
ECCT/25/11/02 | DELIVER-02 IGHID 12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Deborah Chepngeno Langat Site(s) in Kenya 1. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) 2. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (MUCRC), ELDORET (Uasin Gishu county) |
25-06-2026 |
View |
569. |
ECCT/26/04/02 | IGHID 12430/DELIVER-02 IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Charity Wambui Kanyoro Site(s) in Kenya 1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county) 2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) |
25-06-2026 |
View |
570. |
ECCT/25/12/01 | Accetability testing Study Assessing the acceptability of enhanced multiple micronutrient supplements among pregnant women in Bungoma County |
Principal Investigator(s) 1. Zipporah Nekesa Bukania Site(s) in Kenya Tongaren Subcounty, Bungoma County |
14-07-2026 |
View |